Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 6293-6300

  Sanjanwala, Bharati ^a   Draghi, Monia ^a,b   Norman, Paul J ^a   Guethlein, Lisbeth A ^a   Parham, Peter ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BW4 EPITOPE; EPITOPE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; LEUCINE; UNCLASSIFIED DRUG; HLA BW4; HLA-BW4; KIR3DL1 PROTEIN, HUMAN; PEPTIDE;

ALPHA HELIX; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MUTAGENESIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; BIOSYNTHESIS; CELL CLONE; COMPARATIVE STUDY; CYTOTOXICITY TEST; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; METABOLISM; PROTEIN BINDING; PROTEIN MOTIF; SITE DIRECTED MUTAGENESIS;

AMINO ACID MOTIFS; CLONE CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; HLA-B ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; POLYMORPHISM, GENETIC; PROTEIN BINDING; RECEPTORS, KIR3DL1;

EID: 58749090229     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.6293     Document Type: Article

References (44)

1. Bashirova, A. A., M. P. Martin, D. W. McVicar, and M. Carrington. 2006. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7: 277-300. (Pubitemid 44627931)
2. Norman, P. J., L. Abi-Rached, K. Gendzekhadze, D. Korbel, M. Gleimer, D. Rowley, D. Bruno, C. V. Carrington, D. Chandanayingyong, Y. H. Chang, et al. 2007. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 39: 1092-1099. (Pubitemid 47340657)
3. Trowsdale, J. 2001. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15: 363-374. (Pubitemid 32907384)
4. Wan, A. M., P. Ennis, P. Parham, and N. Holmes. 1986. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J. Immunol. 137: 3671-3674.
5. Adams, E. J., and P. Parham. 2001. Species-specific evolution of MHC class I genes in the higher primates. Immunol. Rev. 183: 41-64.
6. Luque, I., R. Solana, M. D. Galiani, R. Gonzalez, F. Garcia, J. A. Lopez de Castro, and J. Pena. 1996. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur. J. Immunol. 26: 1974-1977. (Pubitemid 26283178)
7. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
8. Martin, M. P., Y. Qi, X. Gao, E. Yamada, J. N. Martin, F. Pereyra, S. Colombo, E. E. Brown, W. L. Shupert, J. Phair, et al. 2007. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39: 733-740.
9. Boyington, J. C., and P. D. Sun. 2002. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38: 1007-1021.
10. Khakoo, S. I., R. Geller, S. Shin, J. A. Jenkins, and P. Parham. 2002. The D0 domain of KIR3D acts as a major histocompatibility complex class I binding enhancer. J. Exp. Med. 196: 911-921.
11. Peruzzi, M., K. C. Parker, E. O. Long, and M. S. Malnati. 1996. Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells. J. Immunol. 157: 3350-3356. (Pubitemid 126449146)
12. Lopez de Castro, J. A. 2005. HLA-B27: protraying immunodominant viral epitopes. Eur. J. Immunol. 35: 336-340.
13. Stewart-Jones, G. B., K. di Gleria, S. Kollnberger, A. J. McMichael, E. Y. Jones, and P. Bowness. 2005. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur. J. Immunol. 35: 341-351.
14. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37. (Pubitemid 46033585)
15. Valiante, N. M., M. Uhrberg, H. G. Shilling, K. Lienert-Weidenbach, K. L. Arnett, A. D'Andrea, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7: 739-751.
16. Yssel, H., J. E. De Vries, M. Koken, W. Van Blitterswijk, and H. Spits. 1984. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. J. Immunol. Methods 72: 219-227. (Pubitemid 14092011)
17. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77: 51-59. (Pubitemid 19125653)
18. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85: 227-231.
19. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1993. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J. Exp. Med. 178: 1321-1336. (Pubitemid 23277364)
20. Barnstable, C. J., W. F. Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14: 9-20.
21. Brodsky, F. M., and P. Parham. 1982. Evolution of HLA antigenic determinants: species cross-reactions of monoclonal antibodies. Immunogenetics 15: 151-166.
22. Brodsky, F. M., and P. Parham. 1982. Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants. J. Immunol. 128: 129-135.
23. Draghi, M., N. Yawata, M. Gleimer, M. Yawata, N. M. Valiante, and P. Parham. 2005. Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood 105: 2028-2035. (Pubitemid 40731788)
24. 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell. Immunol. 14: 284-302.
25. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229.
26. Gumperz, J. E., L. D. Barber, N. M. Valiante, L. Percival, J. H. Phillips, L. L. Lanier, and P. Parham. 1997. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J. Immunol. 158: 5237-5241.
27. Maenaka, K., T. Maenaka, H. Tomiyama, M. Takiguchi, D. I. Stuart, and E. Y. Jones. 2000. Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes. J. Immunol. 165: 3260-3267. (Pubitemid 30728181)
28. Malnati, M. S., M. Peruzzi, K. C. Parker, W. E. Biddison, E. Ciccone, A. Moretta, and E. O. Long. 1995. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267: 1016-1018.
29. Willcox, B. E., L. M. Thomas, and P. J. Bjorkman. 2003. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 4: 913-919.
30. Sakaguchi, T., M. Ibe, K. Miwa, Y. Kaneko, S. Yokota, K. Tanaka, and M. Takiguchi. 1997. Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101). Immunogenetics 45: 259-265. (Pubitemid 27077774)
31. Gebreselassie, D., H. Spiegel, and S. Vukmanovic. 2006. Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum. Immunol. 67: 894-906. (Pubitemid 44828201)
32. Kikuchi, A., T. Sakaguchi, K. Miwa, Y. Takamiya, H. G. Rammensee, Y. Kaneko, and M. Takiguchi. 1996. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics 43: 268-276. (Pubitemid 26073254)
33. Takamiya, Y., T. Sakaguchi, K. Miwa, and M. Takiguchi. 1996. Role of HLAB* 5101 binding nonamer peptides in formation of the HLA-Bw4 public epitope. Int. Immunol. 8: 1027-1034. (Pubitemid 26235706)
34. Takemoto, Y., T. Naruse, K. Namba, N. Kitaichi, M. Ota, Y. Shindo, N. Mizuki, A. Gul, W. Madanat, H. Chams, et al. 2008. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease. Tissue Antigens. 72: 347-353.
35. Akoglu, T. F., H. Direskeneli, H. Yazici, and R. Lawrence. 1990. TNF, soluble IL-2R, and soluble CD-8 in Behcet's disease. J. Rheumatol. 17: 1107-1108. (Pubitemid 20278037)
36. Hamzaoui, K., K. Ayed, A. Slim, M. Hamza, and J. Touraine. 1990. Natural killer cell activity, interferon-γ and antibodies to herpes viruses in patients with Behcet's disease. Clin. Exp. Immunol. 79: 28-34. (Pubitemid 20042128)
37. Kaneko, F., Y. Takahashi, R. Muramatsu, K. Adachi, Y. Miura, A. Nakane, and T. Minagawa. 1985. Natural killer cell numbers and function in peripheral lymphoid cells in Behcet's disease. Br. J. Dermatol. 113: 313-318. (Pubitemid 15246606)
38. Takeno, M., Y. Shimoyama, J. Kashiwakura, H. Nagafuchi, T. Sakane, and N. Suzuki. 2004. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behcet's disease. Rheumatol. Int. 24: 212-216. (Pubitemid 39062491)
39. Seo, J., J. S. Park, J. H. Nam, D. Bang, S. Sohn, E. S. Lee, and K. S. Park. 2007. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. Tissue Antigens 70: 307-313. (Pubitemid 47340735)
40. Yawata, M., N. Yawata, M. Draghi, F. Partheniou, A. M. Little, and P. Parham. 2008. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK cell repertoires towards a balance of missing self-response. Blood 112: 2369-2380.
41. Middleton, D., A. Meenagh, C. Sleator, P. A. Gourraud, T. Ayna, H. Tozkir, A. A. Kose, G. Azizleri, and A. S. Diler. 2007. No association of KIR genes with Behcet's disease. Tissue Antigens 70: 435-438.
42. Menssen, R., P. Orth, A. Ziegler, and W. Saenger. 1999. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. J. Mol. Biol. 285: 645-653. (Pubitemid 29041798)
43. Smith, K. J., S. W. Reid, K. Harlos, A. J. McMichael, D. I. Stuart, J. I. Bell, and E. Y. Jones. 1996. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity 4: 215-228.
44. Smith, K. J., S. W. Reid, D. I. Stuart, A. J. McMichael, E. Y. Jones, and J. I. Bell. 1996. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity 4: 203-213. (Pubitemid 126349697)